Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M191,180Revenue (TTM) $M49,411Net Margin (%)12.8Altman Z-Score2.3
Enterprise Value $M215,516EPS (TTM) $2.7Operating Margin %15.6Piotroski F-Score7
P/E(ttm)30.0Beneish M-Score-2.8Pre-tax Margin (%)14.9Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %-2.6Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %-4.1Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow20.9y-y EBITDA Growth Rate %4.7ROA % (ttm)4.8Higher Current Ratio y-yY
Dividend Yield %3.4PEG--ROE % (ttm)8.8Less Shares Outstanding y-yY
Payout Ratio %102Shares Outstanding M2,366ROIC % (ttm)7.2Gross Margin Increase y-yY

Gurus Latest Trades with NVS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NVS is held by these investors:



NVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Novartis Bioventures Ltd10% Owner 2014-09-22Buy36,111$135-40.26view

Quarterly/Annual Reports about NVS:

    News about NVS:

    Articles On GuruFocus.com
    Dodge & Cox Buys Express Scripts, Bristol-Myers, HP May 25 2017 
    DURECT and Sandoz have Signed a $293 Million Development and Commercialization Agreement for POSIMIR May 08 2017 
    Jerome Dodson Comments on Novartis Apr 26 2017 
    Novartis Releases 1st-Quarter Earnings Apr 26 2017 
    Jerome Dodson Buys 2 Stocks, Sells 2 in 1st Quarter Apr 17 2017 
    Gilead Sciences Raises Dividend by Double Digits Feb 22 2017 
    Novartis Has Bright Future Feb 01 2017 
    2 Top Health Care Dividend Stocks Jan 12 2017 
    7 Stocks With Low P/S Ratios Jan 11 2017 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 

    More From Other Websites
    Changes in Sanofi’s Valuation after Its 1Q17 Earnings May 26 2017
    I Still Can't Believe Juno Therapeutics Spent $46.4 Million on This Failed Drug May 25 2017
    Could There Be a Revenue Fall for Neulasta in 2017? May 25 2017
    Alnylam Pharmaceuticals (ALNY) Progressing Well on Pipeline May 25 2017
    Novartis (NVS) Reports Positive Data on Ultibro Breezhaler May 25 2017
    Cambridge largely spared as Novartis cuts hundreds of jobs May 24 2017
    Neupogen and Enbrel Could See Falling Revenues in 2017 May 24 2017
    Wide-Moat Roche Is Undervalued May 24 2017
    The Current State Of The Breast Cancer Treatment Space May 23 2017
    Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion May 22 2017
    Will Novartis' MS Drug Stomp Celgene's Before It Even Hits The Market? May 22 2017
    Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab May 19 2017
    CHMP backs Novartis's Zykadia for first-line use in lung cancer May 19 2017
    Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments May 18 2017
    Novartis to cut around 500 jobs in Switzerland, add 350 May 18 2017
    Today's Research Reports on Stocks to Watch: GlaxoSmithKline and Novartis May 16 2017
    GlaxoSmithKline Could Buy Out Partner Novartis May 15 2017
    Can Teva Hold Its Own In Bringing Migraine Drugs To Market? May 12 2017
    Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit May 08 2017
    DURECT and Sandoz have Signed a $293 Million Development and Commercialization Agreement for... May 08 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)